Ayola Akim Adegnika Selected Research

Hemolysis

12/2019	Determinants of post-malarial anemia in African children treated with parenteral artesunate.
6/2014	Delayed hemolysis after treatment with parenteral artesunate in African children with severe malaria--a double-center prospective study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ayola Akim Adegnika Research Topics

Disease

16	Malaria 12/2023 - 12/2012
15	Infections 10/2023 - 01/2011
4	Falciparum Malaria (Plasmodium falciparum Malaria) 12/2021 - 01/2018
3	Parasitic Diseases (Parasitic Disease) 12/2021 - 06/2012
2	Gastroenteritis 04/2024 - 11/2021
2	Tuberculosis (Tuberculoses) 06/2023 - 12/2021
2	Schistosomiasis (Bilharziasis) 01/2023 - 09/2021
2	Drug-Related Side Effects and Adverse Reactions 03/2021 - 01/2021
2	Hemolytic Anemia 01/2021 - 01/2016
2	Hemolysis 12/2019 - 06/2014
1	Helminthiasis (Helminthiases) 01/2023
1	Extensively Drug-Resistant Tuberculosis 12/2021
1	Neglected Diseases 07/2021
1	HIV Infections (HIV Infection) 03/2021
1	Growth Disorders 01/2021
1	Scabies (Sarcoptic Mange) 01/2020
1	Hemoglobinopathies 12/2019
1	Anemia 12/2019
1	Inflammation (Inflammations) 10/2019
1	Fever (Fevers) 01/2018
1	Sickle Cell Trait 01/2018
1	Parasitemia 01/2018
1	Glucosephosphate Dehydrogenase Deficiency 01/2016
1	Coinfection 01/2014
1	Human Influenza (Influenza) 04/2012
1	Tetanus 04/2012

Drug/Important Bio-Agent (IBA)

6	VaccinesIBA 04/2024 - 12/2012
4	ArtesunateIBA 12/2021 - 06/2014
4	AntigensIBA 01/2016 - 04/2012
3	Anti-Bacterial Agents (Antibiotics)IBA 10/2023 - 01/2021
3	artemisinin (artemisinine)IBA 12/2021 - 01/2017
3	Antimalarials (Antimalarial Agents)IBA 01/2021 - 01/2016
3	Hemoglobins (Hemoglobin)IBA 12/2019 - 06/2014
2	Indicators and Reagents (Reagents)IBA 06/2023 - 11/2019
2	Rifampin (Rifampicin)FDA LinkGeneric 06/2023 - 12/2021
2	Immunoglobulin G (IgG)IBA 01/2023 - 04/2012
2	Tetracycline (Achromycin)FDA LinkGeneric 12/2022 - 01/2021
2	eravacyclineIBA 12/2022 - 01/2021
2	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 01/2022 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 10/2019 - 01/2017
2	Malaria VaccinesIBA 12/2012 - 12/2012
1	Pyrethrins (Pyrethroids)FDA Link 12/2023
1	InsecticidesIBA 12/2023
1	bendiocarbIBA 12/2023
1	MacrolidesIBA 10/2023
1	AminoglycosidesIBA 10/2023
1	Proteins (Proteins, Gene)FDA Link 03/2023
1	Histidine (L-Histidine)FDA Link 03/2023
1	Immunoglobulin M (IgM)IBA 01/2023
1	proguanil drug combination atovaquone (malarone)FDA Link 12/2021
1	pyronaridineIBA 12/2021
1	EpitopesIBA 11/2021
1	Praziquantel (Biltricide)FDA Link 09/2021
1	EnzymesIBA 03/2021
1	AminoquinolinesIBA 01/2021
1	TetracyclinesIBA 01/2021
1	OF 743IBA 01/2021
1	benzyl benzoate (Ansar)FDA Link 01/2020
1	Erythropoietin FDA Link 12/2019
1	Calcitriol Receptors (Calcitriol Receptor)IBA 10/2019
1	Chloroquine (Aralen)FDA LinkGeneric 10/2019
1	piperaquineIBA 01/2018
1	fosmidomycinIBA 01/2018
1	ArtemisininsIBA 01/2017
1	ChemokinesIBA 02/2015
1	CTLA-4 AntigenIBA 06/2012
1	CytokinesIBA 01/2011
1	LigandsIBA 01/2011
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2011

Therapy/Procedure

4	Therapeutics 12/2021 - 06/2014
1	Optical Devices 01/2023
1	Drug Therapy (Chemotherapy) 12/2021
1	Mass Drug Administration 07/2021
1	Polypharmacy 03/2021
1	Aftercare (After-Treatment) 06/2014
1	Ligation 01/2011